(Total Views: 477)
Posted On: 05/18/2025 9:54:54 PM
Post# of 153342
Think it is pretty clear that Roche is the partner for oncology.
The Tnbc patients all took the same PD-L1 inhibitor Teccetriq (Roche)
Avastin (Roche) is already being studied in combination with leronlimab in a phase 2 clinical trial for patients with relapsed/refractory microsatellite stable metastatic colorectal cancer.
Switzerland headquarter is probably 2-3 hrs from ESMO conference, where Cytodyn took the whole executive team.
The Tnbc patients all took the same PD-L1 inhibitor Teccetriq (Roche)
Avastin (Roche) is already being studied in combination with leronlimab in a phase 2 clinical trial for patients with relapsed/refractory microsatellite stable metastatic colorectal cancer.
Switzerland headquarter is probably 2-3 hrs from ESMO conference, where Cytodyn took the whole executive team.
(16)
(0)Scroll down for more posts ▼
